﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Maad Rayan Publishing Company</PublisherName>
      <JournalTitle>Biomedicine Advances</JournalTitle>
      <Issn>3080-0382</Issn>
      <Volume>3</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2026</Year>
        <Month>04</Month>
        <DAY>27</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Artificial intelligence in medical publishing: An overview of the challenges and opportunities</ArticleTitle>
    <FirstPage>42</FirstPage>
    <LastPage>43</LastPage>
    <ELocationID EIdType="doi">10.34172/bma.66</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Neda</FirstName>
        <LastName>Roshanravan</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-8173-6532</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>EDITORIAL</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/bma.66</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2026</Year>
        <Month>01</Month>
        <Day>09</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2026</Year>
        <Month>03</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <Abstract>Author’s Biosketch Dr. Neda Roshanravan earned her PhD. in Nutritional Sciences with a specialization in Medical Biotechnology from Tabriz University of Medical Sciences, Tabriz, Iran, in 2017. Her doctoral studies focused on Cellular and Molecular Nutrition within the field of Medical Biotechnology. Her research primarily focuses on identifying diagnostic and prognostic biomarkers and exploring molecular mechanisms underlying disease pathogenesis, with a major focus on chronic diseases, particularly cardiovascular diseases, diabetes, and cancer. In recognition of her scientific contributions, she has been ranked among the top 2% of the world’s most cited scientists in 2025, according to the annual analysis conducted by Stanford University and published by Elsevier.</Abstract>
  </Article>
</ArticleSet>